Although semaglutide is effective, many people discontinue it due to high costs, persistent side effects, medication shortages, weight-loss plateaus, reaching their goal weight, or simply feeling physically or mentally tired of long-term injections
Add bacteriostatic water slowly along the vial wall
10.1046/j.1471-4159.1995.64051965.x J
As a result, we believe that these three clinical parameters, including ALT, body weight, and HbA1c (ABC), can become the milestones in the treatment of NASH (Fig
Your GP or diabetes specialist will assess your individual circumstances, including your current metabolic control, kidney function, cardiovascular status, and other medications
Groundbreaking clinical trials published in late 2023 and 2024 show that semaglutide, approved in 2019 for treating diabetes and in 2021 for weight management, also reduces rates of heart disease and kidney disease, and reduces tissue and systemic inflammation